細胞生存率アッセイの世界市場規模、シェア、成長分析：製品別、用途別、エンドユーザー別、地域別 - 産業予測（2024年～2031年）

世界の細胞生存率アッセイの市場規模は、2022年に13億8,000万米ドルと評価され、2023年の15億2,000万米ドルから2031年には32億4,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは9.94％で成長する見通しです。

世界の細胞生存率アッセイ（CVA）市場は、医薬品開発需要の増加や製薬・バイオテクノロジー分野の進歩に牽引され、大きな成長を遂げています。細胞の健全性を示す重要な指標である細胞生存率は、毒性因子を含む化学的または物理的な要因によって影響を受けます。CVAは、薬剤や病原体に対する細胞の反応を評価するために不可欠なツールであり、初期段階の創薬に欠かせないものとなっています。これらのアッセイは、化合物の効率、毒性、安全性プロファイルを評価するのに役立ち、これらは医薬品開発に不可欠です。製薬業界が新規治療と薬物の安全性に重点を置く中、細胞生存率アッセイの需要は拡大し、医学研究と薬物検査における用途がさらに拡大すると予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模の推定
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給需要動向分析
• セグメント別の機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 技術の進歩
• 規制情勢
• 特許分析
• バリューチェーン分析
• ケーススタディ分析
• 顧客と購買基準の分析
• PESTEL分析
• マクロ経済指標
• 市場の魅力指数

細胞生存率アッセイ市場規模：製品別、CAGR（2024年～2031年）

• 市場概要
• 消耗品
• 機器

細胞生存率アッセイ市場規模：用途別、CAGR（2024年～2031年）

• 市場概要
• 基礎研究
• 幹細胞研究
• 創薬と開発
• 臨床・診断用途
• その他の用途

細胞生存率アッセイ市場規模：エンドユーザー別、CAGR（2024年～2031年）

• 市場概要
• 学術研究機関
• 製薬・バイオテクノロジー企業
• 病院・診断検査室
• その他のエンドユーザー

細胞生存率アッセイ市場規模&とCAGR（2024年～2031年）

• 北米（製品、用途、エンドユーザー）
  • 米国
  • カナダ
• 欧州（製品、用途、エンドユーザー）
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州
• アジア太平洋（製品、用途、エンドユーザー）
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ（製品、用途、エンドユーザー）
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ（製品、用途、エンドユーザー）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別のシェア分析
  • 収益の前年比比較（2021年～2023年）

主要企業プロファイル

• F. Hoffmann-La Roche AG
• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Macrogen Inc
• DiscoverX Corporation
• Corning Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Perkinelmer, Inc.
• Biognosys
• Cell Signaling Technology, Inc.
• Lebermuth, Inc.
• Eurofins DiscoverX Products
• GE Healthcare
• Beckman Coulter,Inc.

結論と推奨事項

Global Cell Viability Assays Market size was valued at USD 1.38 Billion in 2022 and is poised to grow from USD 1.52 Billion in 2023 to USD 3.24 Billion by 2031, growing at a CAGR of 9.94% in the forecast period (2024-2031).

The global Cell Viability Assays (CVA) market is witnessing significant growth, driven by the increasing demand for drug development and advancements in the pharmaceutical and biotechnology sectors. Cell viability, a critical indicator of cell health, is affected by chemical or physical agents, including toxicity factors. CVAs are essential tools for assessing cellular responses to drugs or pathogens, making them indispensable in early-stage drug discovery. These assays help evaluate compound efficiency, toxicity, and safety profiles, which are vital for drug development. As the pharmaceutical industry focuses on novel therapies and drug safety, the demand for cell viability assays is expected to grow, further expanding their applications in medical research and drug testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Viability Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Viability Assays Market Segmental Analysis

Global Cell Viability Assays Market is segmented by Product, application, end user and region. Based on Product, the market is segmented into Consumables, Instruments. Based on application, the market is segmented into Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications. Based on end user, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Viability Assays Market

The continuous investment in research and development by manufacturers to introduce new drugs for treating various conditions is a significant driver in the global Cell Viability Assays market. The pharmaceutical and biotechnology industries heavily rely on cell viability assays for critical processes such as drug discovery, toxicity testing, and evaluating drug efficiency. This ongoing development and innovation within these sectors are driving the growing demand for advanced assays, as they play a crucial role in ensuring the safety and efficacy of new therapeutics. As these industries expand, the need for more precise and reliable assays continues to rise, further fueling market growth.

Restraints in the Global Cell Viability Assays Market

The global Cell Viability Assays market faces significant restraints due to strict regulations on the use of reagents, which impede market growth. Additionally, the high cost of necessary instruments further limits expansion. Certain cell-based assays require specific reagents, such as antibodies, growth factors, cytokines, or fluorescent dyes, to detect and measure cellular responses. These specialized reagents often face limitations due to intellectual property rights, licensing agreements, or limited commercial availability, further hindering market development. As a result, the combination of regulatory restrictions and high costs of both reagents and instruments presents a substantial challenge to the growth of the cell viability assay market.

Market Trends of the Global Cell Viability Assays Market

Continuous innovation in the characteristics of cell viability assays is driving the growth of the global market. Manufacturers are increasingly integrating these assays with emerging technologies such as artificial intelligence (AI) and machine learning, significantly enhancing data analysis, interpretation, and overall assay performance. These advancements not only improve the accuracy and efficiency of cell viability testing but also contribute to more reliable and faster results, which is fostering the growth of the market. As these technologies evolve, the demand for advanced, high-performance cell viability assays continues to rise, further accelerating market expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Cell Viability Assays Market Size byProduct & CAGR (2024-2031)

• Market Overview
• Consumables
• Instruments

Global Cell Viability Assays Market Size byApplication & CAGR (2024-2031)

• Market Overview
• Basic Research
• Stem Cell Research
• Drug Discovery & Development
• Clinical & Diagnostic Applications
• Other Applications

Global Cell Viability Assays Market Size by End User & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Other End Users

Global Cell Viability Assays Market Size & CAGR (2024-2031)

• North America, (Product, Application, End User)
  • US
  • Canada
• Europe, (Product, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiscoverX Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perkinelmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biognosys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lebermuth, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter,Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation